A Medical Device Daily
Sensors for Medicine and Science (Germantown, Maryland) a clinical-stage company pioneering breakthrough technology that could "dramatically improve" continuous glucose monitoring for people with diabetes, reported the completion of a $10 million financing with a strategic investor.
The unidentified new investor purchased shares of the company's existing Series C preferred stock.
No product development or intellectual property rights were transferred as a result of this investment.
Previous venture investors in Sensors for Medicine and Science, include New Enterprise Associates (Menlo Park, California) HealthCare Ventures (Princeton, New Jersey), Rho Management (New York) Anthem Capital (Vancouver) and Abingworth Bioventures (London).